A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
Clinical trial NCT06333249 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06333249
- Sponsor
- Beacon Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-13
- Primary completion
- 2023-04-11
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.